Thank you Mac9
it validates my exaggerated future Sp
- Forums
- ASX - By Stock
- PER
- Ann: Phase IIb study of ATL1102 in DMD completes recruitment
PER
percheron therapeutics limited
Add to My Watchlist
20.0%
!
1.2¢

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-146
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
0.002(20.0%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $83.34K | 6.986M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 416726 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 1000000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.014 |
1 | 150000 | 0.013 |
1 | 1200000 | 0.012 |
7 | 945768 | 0.011 |
3 | 4438095 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 216666 | 2 |
0.011 | 2911423 | 4 |
0.012 | 1139598 | 3 |
0.013 | 1000000 | 1 |
0.014 | 2072000 | 4 |
Last trade - 10.39am 26/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online